








































Fig. 6. Mitigation of escape risk using dual antibody combinations. (A) Replication competent vesicular stomatitis 
virus (rcVSV) whose genome expressed SARS-CoV-2 WA-1 was incubated with serial dilutions of the indicated 
antibodies and wells with cytopathic effect (CPE) were passaged forward into subsequent rounds (fig. S8) after 48-
72 hours. Total supernatant RNA was harvested and viral genomes shotgun sequenced to determine the frequency 
of amino acid changes. Shown are the spike protein amino acid/position change and frequency as a logo plot Amino 
acid changes observed in two independent experiments are indicated in blue and green letters. (B) The indicated 
Spike protein mutations predicted by structural analysis (Fig. 3) or observed by escape analysis (Fig. 6A) were 
expressed on the surface of HEK293T cells and binding to the indicated antibody was measured using flow 
cytometry. Data are shown as Mean Fluorescence intensity (MFI) normalized to the MFI for the same antibody 
against the WA-1 parental binding. Percent change is indicated by a color gradient from red (increased binding, Max 
200%) to white (no change, 100%) to blue (no binding, 0%). (C) ICso and ICso values for the indicated antibodies 
against WA-1 and the mutations predicted by structural analysis (Fig. 3) or observed by escape analysis (Fig. 6A). 
Ranges are indicated by colors white(> 10000 ng/ml). light blue (1000-10000 ng/ml). yellow (100-1000 ng/ml), 
orange (50-100 ng/ml), red (10-50 ng/ml)  and maroon (1-10 ng/ml). (D) Negative stain 3D reconstruction of the 
